286836-04-2 Usage
Uses
Used in Organic Synthesis:
5-BROMO-7-FLUOROBENZOFURAN is used as a key intermediate in organic synthesis for the production of various chemical compounds. Its unique structure allows for the creation of a wide range of derivatives, making it a valuable building block in the synthesis of complex organic molecules.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 5-BROMO-7-FLUOROBENZOFURAN is used as a starting material for the development of new pharmaceuticals. Its ability to modulate various biological targets has shown promise in the treatment of various diseases and conditions, making it a promising candidate for drug discovery and development.
Used in Drug Development:
5-BROMO-7-FLUOROBENZOFURAN is utilized in drug development as a potential therapeutic agent. Its pharmacological properties have been investigated for its potential use in treating a variety of health issues, highlighting its importance in the advancement of medical treatments.
Used in Chemical Research:
5-BROMO-7-FLUOROBENZOFURAN is also used in chemical research to study the effects of bromine and fluorine substituents on the properties and reactivity of benzofuran derivatives. This research contributes to the understanding of structure-activity relationships and the development of novel chemical compounds with specific applications.
Overall, 5-BROMO-7-FLUOROBENZOFURAN is a multifaceted compound with applications spanning across organic synthesis, medicinal chemistry, drug development, and chemical research, showcasing its significance in the field of chemistry and medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 286836-04-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,6,8,3 and 6 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 286836-04:
(8*2)+(7*8)+(6*6)+(5*8)+(4*3)+(3*6)+(2*0)+(1*4)=182
182 % 10 = 2
So 286836-04-2 is a valid CAS Registry Number.
286836-04-2Relevant articles and documents
PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES
-
Paragraph 0081, (2014/09/29)
Provided is a compound represented by the following general formula (I), or a pharmaceutically acceptable salt thereof. This novel compound has a glycogen-synthase activation ability, but activates a receptor PPAR to a low degree and is highly safe. In th
TRIAZOLONES AS FATTY ACID SYNTHASE INHIBITORS
-
Page/Page column 122, (2011/09/19)
This invention relates to the use of triazolone derivatives for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of triazolones in the treatment of cancer.
Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists
-
Page/Page column 22, (2010/11/08)
The present invention provides serotonergic aminoalkylbenzofurans of Formula (I): where R, R1, R2, R3, R4, R4′, R5, R5′, and R12 are as described in the specification.
SEROTONERGIC BENZOFURANS
-
Page/Page column 17, (2010/02/04)
The present invention provides serotonergic benzofurans of Formula (I): where A, R, R, R, R, and R are as described in the specification.
BENZOFURYLPIPERAZINES AND BENZOFURYLHOMOPIPERAZINES: SEROTONIN AGONISTS
-
, (2013/12/12)
The present invention provides serotonergic benzofurylpiperazines of Formula I: where: A is a piperazine of formula: and R, R1, R2, R3, R4, R5, R5', R6, R6', R7, R7', R8, and R8' are as described in the specification.